UnitedHealth Group (NYSE:UNH) Shares Gap Up Following Better-Than-Expected Earnings

UnitedHealth Group Incorporated (NYSE:UNH)’s stock price gapped up before the market opened on Tuesday after the company announced better than expected quarterly earnings. The stock had previously closed at $378.52, but opened at $397.63. UnitedHealth Group shares last traded at $374.7850, with a volume of 3,137,251 shares trading hands.

The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. UnitedHealth Group’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the company earned $2.59 EPS.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s payout ratio is 59.72%.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted third-quarter earnings of $4.69 per share, ahead of the $4.12 analyst consensus and up from $2.92 a year earlier. Reported net income was $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the prior-year quarter. UnitedHealth Group Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: The company raised its full-year 2026 earnings outlook to approximately $19.50-$20.00 per share, signaling greater confidence in profitability and supporting the stock’s rally. UnitedHealth Group tops estimates and hikes profit outlook
• Positive Sentiment: Medical-cost management showed improvement, a key issue for health insurers. UnitedHealth also cited progress from value-based care and artificial-intelligence investments, suggesting potential support for longer-term margins and efficiency. UnitedHealth Earnings Beat Wall Street Estimates
• Neutral Sentiment: Optum Health revenue declined, creating a potential constraint on overall growth even as the company delivered better earnings and raised guidance. Investors are likely to watch whether improved margins can offset weaker top-line performance. UnitedHealth raises guidance as Optum Health revenue slips

Analysts Set New Price Targets

UNH has been the subject of several recent analyst reports. Wells Fargo & Company raised their target price on UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Erste Group Bank lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. The Goldman Sachs Group increased their price objective on UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a research note on Friday, July 17th. Morgan Stanley raised their price objective on UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a research report on Friday, July 17th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $512.00 target price (up from $492.00) on shares of UnitedHealth Group in a research note on Wednesday, September 2nd. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $462.59.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 0.19% of the stock is currently owned by insiders.

Institutional Trading of UnitedHealth Group

Several hedge funds and other institutional investors have recently modified their holdings of the company. Nalls Sherbakoff Group LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $27,000. Wellington Altus USA Inc. grew its position in UnitedHealth Group by 97.1% in the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 33 shares during the last quarter. Lifetime Wealth Management P.C. bought a new position in UnitedHealth Group in the fourth quarter valued at about $29,000. Security National Bank of SO Dak acquired a new position in UnitedHealth Group during the second quarter worth about $29,000. Finally, Aberdeen Wealth Management LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $31,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

The business’s fifty day moving average price is $388.03 and its 200 day moving average price is $381.81. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The stock has a market cap of $337.36 billion, a P/E ratio of 24.19, a PEG ratio of 1.43 and a beta of 0.60.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.